sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride

C17H24N7NaO9S2 — CID 173396990

IUPACsodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride
SMILESNC(=O)OC[C@@H]1[C@H](NC(=O)C(=NOCC(=O)N2CCCCC2)c2csc(N)n2)C(=O)N1S(=O)(=O)O.[H-].[Na+]
InChIInChI=1S/C17H23N7O9S2.Na.H/c18-16-20-9(8-34-16)12(22-33-7-11(25)23-4-2-1-3-5-23)14(26)21-13-10(6-32-17(19)28)24(15(13)27)35(29,30)31;;/h8,10,13H,1-7H2,(H2,18,20)(H2,19,28)(H,21,26)(H,29,30,31);;/q;+1;-1/t10-,13+;;/m1../s1
InChIKeyJEWVILOLDZMMIC-SRSVFUAYSA-N
MW557.54 g/mol
LogP-4.83
Rot. Bonds9

About sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride

sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride (PubChem CID 173396990) has the molecular formula C17H24N7NaO9S2 and a molecular weight of 557.54 g/mol. Its IUPAC name is sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride.

Molecular Properties

Compound Namesodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride
PubChem CID173396990
Molecular FormulaC17H24N7NaO9S2
Molecular Weight557.54 g/mol
Exact Mass557.10
IUPAC Namesodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride
SMILESNC(=O)OC[C@@H]1[C@H](NC(=O)C(=NOCC(=O)N2CCCCC2)c2csc(N)n2)C(=O)N1S(=O)(=O)O.[H-].[Na+]
InChIInChI=1S/C17H23N7O9S2.Na.H/c18-16-20-9(8-34-16)12(22-33-7-11(25)23-4-2-1-3-5-23)14(26)21-13-10(6-32-17(19)28)24(15(13)27)35(29,30)31;;/h8,10,13H,1-7H2,(H2,18,20)(H2,19,28)(H,21,26)(H,29,30,31);;/q;+1;-1/t10-,13+;;/m1../s1
InChIKeyJEWVILOLDZMMIC-SRSVFUAYSA-N
XLogP-4.83
TPSA236.91 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500557.54
LogP ≤ 5-4.83
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride?
The IUPAC name of sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride (CID 173396990) is sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride.
What is the SMILES notation for sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride?
The canonical SMILES for sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride is NC(=O)OC[C@@H]1[C@H](NC(=O)C(=NOCC(=O)N2CCCCC2)c2csc(N)n2)C(=O)N1S(=O)(=O)O.[H-].[Na+].
What is the InChIKey of sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride?
The InChIKey is JEWVILOLDZMMIC-SRSVFUAYSA-N. The full InChI is InChI=1S/C17H23N7O9S2.Na.H/c18-16-20-9(8-34-16)12(22-33-7-11(25)23-4-2-1-3-5-23)14(26)21-13-10(6-32-17(19)28)24(15(13)27)35(29,30)31;;/h8,10,13H,1-7H2,(H2,18,20)(H2,19,28)(H,21,26)(H,29,30,31);;/q;+1;-1/t10-,13+;;/m1../s1.
What are the key properties of sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride?
sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride has a molecular weight of 557.54 g/mol, XLogP of -4.83, 9 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;(2S,3S)-3-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-oxo-2-piperidin-1-ylethoxy)iminoacetyl]amino]-2-(carbamoyloxymethyl)-4-oxoazetidine-1-sulfonic acid;hydride is sourced from PubChem (CID 173396990), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).